Question 1

What is TAFAMIDIS MEGLUMINE used for?

Accepted Answer

TAFAMIDIS MEGLUMINE (brand name Vyndaqel) is a Other indicated for See full prescribing information.

Question 2

How does TAFAMIDIS MEGLUMINE work?

Accepted Answer

TAFAMIDIS MEGLUMINE works through the following mechanism: 12.1 Mechanism of Action Tafamidis is a selective stabilizer of TTR. Tafamidis binds to TTR at the thyroxine binding sites, stabilizing the tetramer and slowing dissociation into monomers, the rate-limiting step in the amyloidogenic process..

Question 3

What are the most common side effects of TAFAMIDIS MEGLUMINE?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for TAFAMIDIS MEGLUMINE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is TAFAMIDIS MEGLUMINE the same as Vyndaqel?

Accepted Answer

Vyndaqel is a brand name for TAFAMIDIS MEGLUMINE. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

TAFAMIDIS MEGLUMINE

Mechanism of Action

Indications

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations